
无数据
无数据
无数据
| CAS Number | 3056-17-5 |
| Catalog Number | AG0030JY(AGN-PC-0O8RH9) |
| Chemical Name | Thymidine, 2',3'-didehydro-3'-deoxy- |
| IUPAC Name | 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione |
| InChI | InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1 |
| InChI Key | XNKLLVCARDGLGL-JGVFFNPUSA-N |
| MDL Number | MFCD00132921 |
| Molecular Formula | C10H12N2O4 |
| Molecular Weight | 224.2133 |
| NSC Number | 759897 |
| SMILES | OC[C@@H]1C=C[C@@H](O1)N1C(NC(C(=C1)C)=O)=O |
| UNII | BO9LE4QFZF |
| Synonyms | 2',3' Didehydro 3' deoxythymidine,
2',3'-Didehydro-2',3'-dideoxythmidine,
2',3'-Didehydro-3'-deoxythymidine,
BMY 27857,
BMY-27857,
BMY27857,
D4T,
Stavudine,
Stavudine, Monosodium Salt,
Zerit,
stavudine,
3056-17-5,
sanilvudine,
Zerit,
2',3'-Didehydro-3'-deoxythymidine,
Estavudina,
Stavudinum,
Zerit Xr,
Zerut XR,
BMY-27857,
Stavudinum [INN-Latin],
2',3'-Anhydrothymidine,
Estavudina [INN-Spanish],
d4T,
Thymidine, 2',3'-didehydro-3'-deoxy-,
ddeThd,
D 4T (nucleoside),
BMY 27857,
3'-Deoxy-2'-thymidinene,
2',3'-Didehydro-3'-deoxythimidine,
Stavudine [USAN:BAN:INN],
D 4T,
Dideoxydidehydrothymidine,
UNII-BO9LE4QFZF,
3'-Deoxy-2',3'-didehydrothymidine,
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine,
NSC 163661,
HSDB 7338,
BO9LE4QFZF,
CHEMBL991,
BRN 0618327,
2'-Thymidinene, 3'-deoxy-,
1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione,
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione,
MLS000028546,
STV,
CHEBI:63581,
XNKLLVCARDGLGL-JGVFFNPUSA-N,
Stavudine (d4T),
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione,
1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE,
NCGC00023212-07,
SMR000058350,
DSSTox_CID_3819,
1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione,
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione,
DSSTox_RID_77198,
DSSTox_GSID_23819,
ddeTyd,
Zent,
Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI),
Stavudine [USAN:INN:BAN],
CAS-3056-17-5,
Zerit(TM),
Sanilvudine (JAN),
3'-Deoxy-2',3'-didehydrothymidine, 98%,
Zerit (TN),
SR-01000075802,
Stavudine (USAN/INN),
D4T & GM-CSF,
Stavudin,
NSC163661,
Stavudine [USAN:USP:INN:BAN],
D4TMBY-27857-3,
PubChem5805,
AC1Q6BSH,
Opera_ID_1281,
3'-deoxythymidin-2'-ene,
D 1413,
AC1L2BQ9,
cid_5155,
3''-deoxy-2''-thymidine,
Lopac0_000336,
SCHEMBL38661,
2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI),
cid_18283,
MLS000759504,
MLS001055348,
MLS001077292,
MLS001424091,
MLS006011922,
BIDD:GT0082,
2',3'-Anhydrothymidine; d4T,
DTXSID1023819,
CTK8B1419,
1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine,
HMS2051O20,
HMS2234C10,
HMS3039O05,
HMS3259L21,
HMS3261C13,
HMS3428C07,
HMS3714N22,
Pharmakon1600-01502339,
ZINC137884,
BCP02952,
HY-B0116,
Tox21_110886,
Tox21_201393,
Tox21_300583,
Tox21_500336,
ABP000995,
ANW-26914,
BBL033763,
BDBM50013111,
MFCD00132921,
NSC759897,
STK801888,
2',3'-Didehydro-3'-deoxy-thymidine,
AKOS005622554,
Tox21_110886_1,
AC-5263,
AN-7246,
CCG-100902,
CS-1872,
DB00649,
KS-1115,
LP00336,
LS-1160,
MCULE-9252477726,
NC00152,
NC00684,
NSC-759897,
RP07238,
KS-00000H34,
2'',3''-didehydro-3''-deoxythymidine,
3''-deoxy-2'',3''-didehydrothymidine,
3'-Deoxy-2',3'-didehydro-D-thymidine,
NCGC00023212-03,
NCGC00023212-04,
NCGC00023212-05,
NCGC00023212-08,
NCGC00023212-09,
NCGC00023212-10,
NCGC00023212-11,
NCGC00023212-12,
NCGC00023212-13,
NCGC00023212-14,
NCGC00254372-01,
NCGC00258944-01,
NCGC00261021-01,
1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2,
AJ-12338,
BC203877,
BR-77340,
CPD000058350,
CPD000673569,
H940,
SAM001246729,
SAM002589948,
SC-03292,
SMR000673569,
ZB004848,
2',3'-didehydro-2',3'-dideoxythymidine,
AB0013374,
AB1009564,
Thymidine, 2',3'-didehydro-, 3'-deoxy-,
D3580,
EU-0100336,
FT-0082665,
FT-0603625,
2'',3''-dideoxy-2'',3''-didehydrothymidine,
C07312,
D00445,
J10003,
S-2155,
AB00383018_18,
056S175,
A820433,
J-700246,
Q-201742,
SR-01000075802-1,
SR-01000075802-4,
2',3'-Didehydro-3'-deoxythymidine, >=98% (TLC),
Z1695906749,
Stavudine, European Pharmacopoeia (EP) Reference Standard,
1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine,
Stavudine, United States Pharmacopeia (USP) Reference Standard,
1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione,
1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd),
1-[(2R,5S)-2,5-Dihydro-5-(hydroxymethyl)-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione,
3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor,
Stavudine for system suitability, European Pharmacopoeia (EP) Reference Standard,
1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-(1H,3H)-dione,
null,
staduvine,
Stavudine, Monosodium Salt,
D0Z8EX,
BMY27857,
Bristol-Myers Brand of Stavudine,
2',3' Didehydro 3' deoxythymidine,
C10H12N2O4,
C10H14N2O4,
CID18283,
DRG-0043,
2',3'-Didehydro-2',3'-dideoxythmidine,
C10-H12-N2-O4,
CS-O-10815,
Bristol-Myers Squibb Brand of Stavudine,
D018119,
1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine,
Thymine, 1-(2,3-dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)-,
Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-(7CI,8CI),
1-((2R,5S)-2,5-dihydro-5-(hydroxymethyl)furan-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione,
3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor,
2',3'-Didehydro-3'-deoxythmidine, 98%, a nucleoside analog that inhibits reverse transcriptase - 1G 1g,
DHT,
DTH,
|
| Complexity | 388 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 224.08g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 16 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 224.216g/mol |
| Monoisotopic Mass | 224.08g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 78.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.8 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P261-P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

